Price fixation of essential drugs hits profitability: Novartis
Tuesday, July 11, 2017
The fixation of ceiling prices of essential drugs by the pharma pricing regulator NPPA has impacted the profitability of the company, drug firm Novartis India has said.
The government’s push for prescribing the drugs by generic names could pose further challenges, Novartis India said in the latest annual report for 2016-17.
Source: Economic Times (link opens in a new window)
- Categories
- Health Care
